Adenovirus: Epidemiology, Global Spread of Novel Serotypes, and Advances in Treatment and Prevention
- PMID: 27486739
- PMCID: PMC7171713
- DOI: 10.1055/s-0036-1584923
Adenovirus: Epidemiology, Global Spread of Novel Serotypes, and Advances in Treatment and Prevention
Abstract
Adenoviruses (AdVs) are DNA viruses that typically cause mild infections involving the upper or lower respiratory tract, gastrointestinal tract, or conjunctiva. Rare manifestations of AdV infections include hemorrhagic cystitis, hepatitis, hemorrhagic colitis, pancreatitis, nephritis, or meningoencephalitis. AdV infections are more common in young children, due to lack of humoral immunity. Epidemics of AdV infection may occur in healthy children or adults in closed or crowded settings (particularly military recruits). The disease is more severe and dissemination is more likely in patients with impaired immunity (e.g., organ transplant recipients, human immunodeficiency virus infection). Fatality rates for untreated severe AdV pneumonia or disseminated disease may exceed 50%. More than 50 serotypes of AdV have been identified. Different serotypes display different tissue tropisms that correlate with clinical manifestations of infection. The predominant serotypes circulating at a given time differ among countries or regions, and change over time. Transmission of novel strains between countries or across continents and replacement of dominant viruses by new strains may occur. Treatment of AdV infections is controversial, as prospective, randomized therapeutic trials have not been conducted. Cidofovir is the drug of choice for severe AdV infections, but not all patients require treatment. Live oral vaccines are highly efficacious in reducing the risk of respiratory AdV infection and are in routine use in the military in the United States, but currently are not available to civilians.
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.
Figures
Similar articles
-
Adenovirus.Semin Respir Crit Care Med. 2011 Aug;32(4):494-511. doi: 10.1055/s-0031-1283287. Epub 2011 Aug 19. Semin Respir Crit Care Med. 2011. PMID: 21858752 Review.
-
Adenovirus: Epidemiology, Global Spread of Novel Types, and Approach to Treatment.Semin Respir Crit Care Med. 2021 Dec;42(6):800-821. doi: 10.1055/s-0041-1733802. Epub 2021 Dec 16. Semin Respir Crit Care Med. 2021. PMID: 34918322
-
High-risk adenovirus-infected pediatric allogeneic hematopoietic progenitor cell transplant recipients and preemptive cidofovir therapy.Pediatr Transplant. 2008 Mar;12(2):219-27. doi: 10.1111/j.1399-3046.2007.00851.x. Pediatr Transplant. 2008. PMID: 18307672
-
Treatment of adenovirus disease in stem cell transplant recipients with cidofovir.Biol Blood Marrow Transplant. 2007 Jan;13(1):74-81. doi: 10.1016/j.bbmt.2006.08.040. Biol Blood Marrow Transplant. 2007. PMID: 17222755 Review.
-
Cidofovir for the treatment of adenoviral infection in pediatric hematopoietic stem cell transplant patients.Transplantation. 2006 May 27;81(10):1398-404. doi: 10.1097/01.tp.0000209195.95115.8e. Transplantation. 2006. PMID: 16732176
Cited by
-
Clinical epidemiology of adenovirus pneumonia among Chinese hospitalized children.Arch Microbiol. 2024 Mar 4;206(4):135. doi: 10.1007/s00203-024-03870-3. Arch Microbiol. 2024. PMID: 38436806
-
E4orf1: The triple agent of adenovirus - Unraveling its roles in oncogenesis, infectious obesity and immune responses in virus replication and vector therapy.Tumour Virus Res. 2024 Feb 28;17:200277. doi: 10.1016/j.tvr.2024.200277. Online ahead of print. Tumour Virus Res. 2024. PMID: 38428735 Free PMC article. Review.
-
Reduction of acute respiratory infections in day-care by non-pharmaceutical interventions: a narrative review.Front Public Health. 2024 Feb 14;12:1332078. doi: 10.3389/fpubh.2024.1332078. eCollection 2024. Front Public Health. 2024. PMID: 38420031 Free PMC article. Review.
-
Human Adenovirus Entry and Early Events during Infection of Primary Murine Neurons: Immunofluorescence Studies In Vitro.Pathogens. 2024 Feb 9;13(2):158. doi: 10.3390/pathogens13020158. Pathogens. 2024. PMID: 38392896 Free PMC article.
-
Combined intravenous ribavirin and recombinant human interferon α1b aerosol inhalation for adenovirus pneumonia with plastic bronchitis in children: a case report and review of literature.Front Pediatr. 2024 Feb 6;12:1295133. doi: 10.3389/fped.2024.1295133. eCollection 2024. Front Pediatr. 2024. PMID: 38379910 Free PMC article.
References
-
- Lynch J P III, Fishbein M, Echavarria M. Adenovirus. Semin Respir Crit Care Med. 2011;32(4):494–511. - PubMed
-
- Ison M G. Adenovirus infections in transplant recipients. Clin Infect Dis. 2006;43(3):331–339. - PubMed
-
- Chang S Y, Lee C N, Lin P H. et al.A community-derived outbreak of adenovirus type 3 in children in Taiwan between 2004 and 2005. J Med Virol. 2008;80(1):102–112. - PubMed
-
- Sandkovsky U, Vargas L, Florescu D F. Adenovirus: current epidemiology and emerging approaches to prevention and treatment. Curr Infect Dis Rep. 2014;16(8):416. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
